Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of YY-201 vs Dutasteride and Tadalafil in Healthy Men
NCT03240939Phase 1Completed
- Sponsor
- Yuyu Pharma
- Start
- Mar 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of YY-201 in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Yuyu Pharma. Primary endpoint: Maximum Plasma Concentration. Started Mar 2017; status: completed.
02
Drugs
YY-201
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT03240939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03240939.